X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-09 | PAHC | Phibro Animal Health Corp | Bendheim Jack | Pres, CEO, 10% | S - Sale | $40.16 | -213 | 55,499 | 0% | -$8,554 | ||||||
2026-01-09 | OKLO | Oklo Inc. | Cochran Caroline | Co-Founder, COO, 10% | S - Sale | $111.84 | -91,628 | 21,822,206 | 0% | -$10,247,603 | ||||||
2026-01-09 | OKLO | Oklo Inc. | Dewitte Jacob | Co-Founder, CEO, 10% | S - Sale | $111.84 | -91,628 | 21,822,206 | 0% | -$10,247,603 | ||||||
2026-01-09 | ELVN | Enliven Therapeutics, Inc. | Patel Anish | COO | S - Sale | $27.99 | -48,300 | 215,011 | -18% | -$1,351,762 | ||||||
2026-01-12 | RBRK | Rubrik, Inc. | McCarthy Brian K. | Pres,Global Sales, Field Ops | S - Sale | $70.88 | -10,000 | 330,772 | -3% | -$708,849 | ||||||
2026-01-09 | HIPO | Hippo Holdings Inc. | McCathron Richard | CEO | S - Sale | $31.52 | -5,000 | 447,704 | -1% | -$157,600 | ||||||
| M | 2026-01-09 | OFIX | Orthofix Medical Inc. | Calafiore Massimo | Pres, CEO | S - Sale | $15.52 | -19,397 | 217,237 | -8% | -$300,955 | |||||
| D | 2026-01-09 | CHYM | Chime Financial, Inc. | Britt Christopher R | CEO | S - Sale+OE | $28.06 | -50,000 | 344,780 | -13% | -$1,402,825 | |||||
2026-01-09 | DOCU | Docusign, Inc. | Grayson Blake Jeffrey | CFO | S - Sale | $70.00 | -6,500 | 111,713 | -5% | -$455,000 | ||||||
2026-01-09 | DOCU | Docusign, Inc. | Thygesen Allan C. | Pres, CEO | S - Sale | $69.60 | -26,250 | 142,261 | -16% | -$1,827,055 | ||||||
2026-01-09 | RPRX | Royalty Pharma Plc | Urist Marshall | EVP, Research, Investments | S - Sale | $40.78 | -20,000 | 86,418 | -19% | -$815,634 | ||||||
2026-01-09 | CHYM | Chime Financial, Inc. | Newcomb Matthew S | CFO | S - Sale | $28.01 | -10,000 | 2,660,911 | 0% | -$280,109 | ||||||
2026-01-12 | SNPS | Synopsys Inc | Lee Janet | GC, Corporate Secretary | S - Sale | $530.00 | -250 | 11,959 | -2% | -$132,500 | ||||||
| D | 2026-01-09 | CHYM | Chime Financial, Inc. | Frankel Adam B | GC | S - Sale+OE | $28.00 | -500 | 218,849 | 0% | -$14,000 | |||||
2026-01-09 | SOUN | Soundhound Ai, Inc. | Stonehocker Timothy | CTO | S - Sale | $12.00 | -29,676 | 544,179 | -5% | -$356,112 | ||||||
| DM | 2026-01-09 | HGTY | Hagerty, Inc. | Ahn Kenneth | Pres, Hagerty Marketplace | S - Sale+OE | $12.87 | -51,350 | 113,593 | -31% | -$660,888 | |||||
2026-01-09 | CIEN | Ciena Corp | Rothenstein David M | SVP, Chief Strategy Officer | S - Sale | $219.28 | -2,500 | 202,194 | -1% | -$548,200 | ||||||
| DM | 2026-01-09 | DBX | Dropbox, Inc. | Houston Andrew | CEO, 10% | S - Sale+OE | $27.52 | -60,000 | 9,427,838 | -1% | -$1,651,456 | |||||
| D | 2026-01-12 | ZYME | Zymeworks Inc. | Hollywood Mark | EVP, COO | S - Sale+OE | $22.67 | -6,120 | 132,913 | -4% | -$138,762 | |||||
| D | 2026-01-12 | UTHR | United Therapeutics Corp | Benkowitz Michael | Pres, COO | S - Sale+OE | $479.51 | -22,500 | 2,648 | -89% | -$10,788,876 | |||||
| M | 2026-01-09 | GRND | Grindr Inc. | Lu James Fu Bin | 10% | S - Sale | $13.22 | -415,307 | 21,738,322 | -2% | -$5,491,482 | |||||
| D | 2026-01-13 | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treasurer | S - Sale+OE | $5.27 | -5,704 | 46,100 | -11% | -$30,060 | |||||
2026-01-12 | AVAV | Aerovironment Inc | McDonnell Kevin Patrick | CFO | S - Sale | $367.60 | -999 | 22,146 | -4% | -$367,232 | ||||||
2026-01-09 | LNWO | Light & Wonder, Inc. | Fine Capital Partners, L.P. | 10% | S - Sale | $103.48 | -15,000 | 8,197,187 | 0% | -$1,552,241 | ||||||
| D | 2026-01-09 | CLPT | Clearpoint Neuro, Inc. | Burnett Joseph | CEO, Pres | S - Sale+OE | $16.12 | -20,000 | 228,624 | -8% | -$322,400 | |||||
2026-01-09 | TNET | Trinet Group, Inc. | Majalya Sidney A. | SVP, CLO, Secretary | S - Sale | $61.86 | -775 | 19,853 | -4% | -$47,942 | ||||||
2026-01-08 | TPET | Trio Petroleum Corp | Pernice Thomas J | Dir | S - Sale | $0.00 | -25,000 | 242,750 | -9% | -$0 | ||||||
2026-01-12 | CIEN | Ciena Corp | Gallagher Patrick | Dir | S - Sale | $227.45 | -11,618 | 50,184 | -19% | -$2,642,486 | ||||||
| D | 2026-01-09 | MDGL | Madrigal Pharmaceuticals, Inc. | Friedman Paul A | Dir | S - Sale+OE | $551.24 | -280 | 842,704 | 0% | -$154,348 | |||||
| D | 2026-01-09 | MDGL | Madrigal Pharmaceuticals, Inc. | Friedman Paul A | Dir | S - Sale+OE | $522.39 | -24,520 | 842,704 | -3% | -$12,808,957 | |||||
2026-01-12 | CIEN | Ciena Corp | Cumello Joseph | SVP, General Mgr. Blue Planet | S - Sale | $229.82 | -11,929 | 49,475 | -19% | -$2,741,531 | ||||||
| D | 2026-01-09 | MDGL | Madrigal Pharmaceuticals, Inc. | Taub Rebecca | Dir | S - Sale+OE | $550.33 | -240 | 1,111,129 | 0% | -$132,080 | |||||
2026-01-09 | ADI | Analog Devices Inc | Nakamura Katsufumi | SVP, Chief Customer Officer | S - Sale | $301.47 | -500 | 12,710 | -4% | -$150,733 | ||||||
| D | 2026-01-12 | LQDA | Liquidia Corp | Krepp Sarah | Chief Human Resource Officer | S - Sale+OE | $37.43 | -13,165 | 140,769 | -9% | -$492,766 | |||||
| D | 2026-01-12 | LQDA | Liquidia Corp | Moomaw Scott | Chief Commercial Officer | S - Sale+OE | $37.43 | -20,533 | 154,514 | -12% | -$768,550 | |||||
| D | 2026-01-12 | LQDA | Liquidia Corp | Kaseta Michael | CFO, COO | S - Sale+OE | $37.43 | -36,932 | 350,919 | -10% | -$1,382,365 | |||||
| D | 2026-01-12 | LQDA | Liquidia Corp | Adair Jason | Chief Business Officer | S - Sale+OE | $37.43 | -13,548 | 184,174 | -7% | -$507,102 | |||||
| D | 2026-01-09 | MDGL | Madrigal Pharmaceuticals, Inc. | Taub Rebecca | Dir | S - Sale+OE | $522.40 | -18,410 | 1,111,129 | -2% | -$9,617,312 | |||||
| D | 2026-01-12 | LQDA | Liquidia Corp | Schundler Russell | GC | S - Sale+OE | $37.43 | -27,289 | 593,894 | -4% | -$1,021,427 | |||||
2026-01-13 | PATH | Uipath, Inc. | Dines Daniel | CEO, COB, 10% | S - Sale | $17.18 | -45,000 | 37,733,882 | 0% | -$773,208 | ||||||
| M | 2026-01-09 | URBN | Urban Outfitters Inc | Hayne Margaret | Co-Pres, CCO | S - Sale | $78.08 | -18,666 | 23,857,028 | 0% | -$1,457,465 | |||||
| D | 2026-01-12 | LQDA | Liquidia Corp | Jeffs Roger | CEO | S - Sale+OE | $37.43 | -66,610 | 2,625,790 | -2% | -$2,493,212 | |||||
| D | 2026-01-12 | LQDA | Liquidia Corp | Boyle Dana | Chief Accounting Officer | S - Sale+OE | $37.43 | -11,047 | 156,700 | -7% | -$413,489 | |||||
| D | 2026-01-12 | LQDA | Liquidia Corp | Saggar Rajeev | Chief Medical Officer | S - Sale+OE | $37.43 | -21,142 | 176,883 | -11% | -$791,345 | |||||
2026-01-09 | JCAP | Jefferson Capital, Inc. / De | Jcf IV Jcap Holding L.P. | 10% | S - Sale | $19.63 | -11,000,000 | 32,721,808 | -25% | -$215,916,800 | ||||||
| M | 2026-01-09 | URBN | Urban Outfitters Inc | Hayne Richard A | CEO, COB, 10% | S - Sale | $78.08 | -40,000 | 23,857,028 | 0% | -$3,123,248 | |||||
2026-01-12 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $97.45 | -5,000 | 4,497,950 | 0% | -$487,231 | ||||||
2026-01-09 | PBF | Pbf Energy Inc. | Control Empresarial De Capitales S.A. De C.V. | Add'l Rep. Persons-see Ex.99-1, 10% | S - Sale | $32.31 | -50,000 | 30,773,498 | 0% | -$1,615,470 | ||||||
| D | 2026-01-09 | CGON | Cg Oncology, Inc. | Mulay James | Dir | S - Sale+OE | $52.47 | -11,145 | 0 | -100% | -$584,799 | |||||
| D | 2026-01-12 | BRKR | Bruker Corp | Munch Mark | EVP, Pres Bruker Nano Inc. | S - Sale+OE | $55.00 | -7,000 | 128,443 | -5% | -$385,000 | |||||
2026-01-12 | TEAM | Atlassian Corp | Cannon-Brookes Michael | CEO, Co-Founder, 10% | S - Sale | $147.15 | -7,665 | 413,910 | -2% | -$1,127,893 | ||||||
2026-01-12 | TEAM | Atlassian Corp | Farquhar Scott | Dir, 10% | S - Sale | $147.15 | -7,665 | 413,910 | -2% | -$1,127,895 | ||||||
2026-01-09 | NOVT | Novanta Inc | Glastra Matthijs | CEO | S - Sale | $130.00 | -6,177 | 133,249 | -4% | -$803,010 | ||||||
| M | 2026-01-09 | RDW | Redwire Corp | Ae Red Holdings, LLC | Dir, 10% | S - Sale | $10.80 | -5,127,071 | 75,860,420 | -6% | -$55,353,876 | |||||
2026-01-09 | DASH | Doordash, Inc. | Brown Shona L | Dir | S - Sale | $222.33 | -1,250 | 33,502 | -4% | -$277,913 | ||||||
2026-01-09 | TWST | Twist Bioscience Corp | Laponis Adam | CFO | S - Sale | $35.26 | -2,738 | 140,031 | -2% | -$96,545 | ||||||
| D | 2026-01-12 | INSM | Insmed Inc | Lewis William | Chair, CEO | S - Sale+OE | $169.00 | -19,215 | 591,315 | -3% | -$3,247,349 | |||||
| M | 2026-01-09 | RKT | Rocket Companies, Inc. | Rizik Matthew | Dir | S - Sale | $22.89 | -5,000 | 7,410,546 | 0% | -$114,430 | |||||
2026-01-09 | INSM | Insmed Inc | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $186.19 | -1,887 | 84,907 | -2% | -$351,341 | ||||||
2026-01-09 | SMTC | Semtech Corp | Fischer Gregory Michael | Dir | S - Sale | $75.50 | -1,034 | 2,857 | -27% | -$78,067 | ||||||
| D | 2026-01-09 | SPT | Sprout Social, Inc. | Howard Justyn Russell | Exec Chair, 10% | S - Sale+OE | $10.70 | -40,000 | 7,417 | -84% | -$427,920 | |||||
2026-01-09 | GDL | Gdl Fund | Gabelli Mario J | Control Person of Adviser, 10% | S - Sale | $8.39 | -800 | 4,950,029 | 0% | -$6,712 | ||||||
| D | 2026-01-12 | MCD | McDonalds Corp | Erlinger Joseph M. | Pres, McDonald's USA | S - Sale+OE | $306.58 | -2,626 | 5,398 | -33% | -$805,079 | |||||
| D | 2026-01-12 | AIR | Aar Corp | Holmes John McClain III | COB, Pres, CEO | S - Sale+OE | $97.50 | -30,000 | 237,064 | -11% | -$2,925,030 | |||||
2026-01-12 | MEGI | Nyli Cbre Global Infrastructure Megatrends Term Fund | Saba Capital Management, L.P. | 10% | S - Sale | $13.72 | -30,586 | 5,354,165 | -1% | -$419,640 | ||||||
2026-01-12 | IIF | Morgan Stanley India Investment Fund, Inc. | Saba Capital Management, L.P. | 10% | S - Sale | $24.60 | -9,884 | 975,681 | -1% | -$243,146 | ||||||
2026-01-08 | SMTC | Semtech Corp | Wilson John Michael | Chief Quality Officer, CTO | S - Sale | $75.12 | -5,000 | 60,066 | -8% | -$375,600 | ||||||
2026-01-12 | ACLX | Arcellx, Inc. | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale | $64.15 | -6,131 | 37,068 | -14% | -$393,286 | ||||||
| DM | 2026-01-09 | LIND | Lindblad Expeditions Holdings, Inc. | Bressler Benjamin | *Founder, CEO of NHA | S - Sale+OE | $15.83 | -291,825 | 23,466 | -93% | -$4,620,124 | |||||
| M | 2026-01-08 | BBIO | Bridgebio Pharma, Inc. | Kumar Neil | CEO | S - Sale | $75.54 | -80,000 | 5,462,909 | -1% | -$6,043,168 | |||||
| D | 2026-01-12 | ZYME | Zymeworks Inc. | Smith Jeffrey T L | EVP, Chief Medical Officer | S - Sale+OE | $22.67 | -9,310 | 26,708 | -26% | -$211,090 | |||||
| D | 2026-01-12 | ZYME | Zymeworks Inc. | Moore Paul Andrew | Chief Scientific Officer | S - Sale+OE | $22.67 | -9,560 | 48,497 | -16% | -$216,759 | |||||
| M | 2026-01-08 | LXU | Lsb Industries, Inc. | Golsen Barry H | Dir | S - Sale | $9.16 | -175,697 | 277,674 | -39% | -$1,609,380 | |||||
2025-05-19 | CXW | Corecivic, Inc. | Prann John R Jr | Dir | S - Sale | $22.52 | -8,000 | 100,396 | -7% | -$180,168 | ||||||
| M | 2026-01-08 | KTOS | Kratos Defense & Security Solutions, Inc. | Rock Stacey G | Pres, KTT Division | S - Sale | $114.53 | -20,568 | 26,487 | -44% | -$2,355,667 | |||||
| D | 2026-01-08 | RDDT | Reddit, Inc. | Slowe Christopher Brian | CTO | S - Sale+OE | $253.89 | -14,000 | 189,878 | -7% | -$3,554,387 | |||||
| D | 2026-01-12 | ZYME | Zymeworks Inc. | Galbraith Kenneth | Chair, CEO | S - Sale+OE | $22.67 | -30,424 | 226,842 | -12% | -$689,819 | |||||
| D | 2026-01-08 | LUNR | Intuitive Machines, Inc. | Altemus Stephen J | CEO, 10% | S - Sale+OE | $20.00 | -12,669 | 13,855,946 | 0% | -$253,419 | |||||
| D | 2026-01-08 | LUNR | Intuitive Machines, Inc. | Crain Timothy Price II | SVP, Chief Growth Officer, 10% | S - Sale+OE | $20.00 | -5,660 | 9,513,390 | 0% | -$113,216 | |||||
2026-01-08 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Officer | S - Sale | $1.82 | -6,888 | 209,951 | -3% | -$12,513 | ||||||
2026-01-08 | ABOS | Acumen Pharmaceuticals, Inc. | Barton Russell | COO | S - Sale | $1.86 | -3,530 | 123,269 | -3% | -$6,562 | ||||||
| M | 2026-01-08 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | GC, Corp Sec | S - Sale | $1.80 | -50,659 | 83,800 | -38% | -$91,073 | |||||
| M | 2026-01-08 | ABOS | Acumen Pharmaceuticals, Inc. | Oconnell Daniel Joseph | CEO | S - Sale | $1.77 | -26,472 | 593,510 | -4% | -$46,954 | |||||
| DM | 2026-01-08 | NTSK | Netskope Inc | Bousquet Raphael | Chief Revenue Offucer | S - Sale+OE | $16.67 | -10,239 | 0 | -100% | -$170,697 | |||||
2026-01-07 | QUBT | Quantum Computing Inc. | Begliarbekov Milan | COO | S - Sale | $11.85 | -2,860 | 24,240 | -11% | -$33,891 | ||||||
2026-01-12 | PATH | Uipath, Inc. | Dines Daniel | CEO, COB, 10% | S - Sale | $16.61 | -45,000 | 37,778,882 | 0% | -$747,432 | ||||||
| DM | 2025-12-30 | EXFY | Expensify, Inc. | Alvarez Divo Carlos Eduardo | Dir | S - Sale+OE | $1.51 | -8,972 | 285,508 | -3% | -$13,507 | |||||
2026-01-08 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $21.28 | -20,000 | 90,422 | -18% | -$425,506 | ||||||
2026-01-09 | BOX | Box Inc | Smith Dylan C | CFO | S - Sale | $29.57 | -17,000 | 1,328,195 | -1% | -$502,656 | ||||||
| DM | 2026-01-07 | MOVE | Movano Inc. | Leabman Michael Aaron | CTO | S - Sale+OE | $7.30 | -7,669 | 34,937 | -18% | -$55,948 | |||||
| DM | 2026-01-05 | MOVE | Movano Inc. | Cogan Jeremy | CFO | S - Sale+OE | $7.89 | -10,097 | 24,406 | -29% | -$79,675 | |||||
2026-01-08 | ASLE | Aersale Corp | Pizzi Enrique | CIO | S - Sale | $7.38 | -1,825 | 83,063 | -2% | -$13,466 | ||||||
| D | 2026-01-08 | GMED | Globus Medical Inc | Kline Kyle | SVP, CFO | S - Sale+OE | $101.10 | -3,594 | 0 | -100% | -$363,353 | |||||
2026-01-08 | GMED | Globus Medical Inc | Norwalk Leslie V | Dir | S - Sale | $101.10 | -2,000 | 10,419 | -16% | -$202,200 | ||||||
2026-01-08 | CWAN | Clearwater Analytics Holdings, Inc. | Das Souvik | CTO | S - Sale | $24.08 | -10,000 | 138,230 | -7% | -$240,825 | ||||||
2026-01-08 | PTCT | Ptc Therapeutics, Inc. | Utter Christine Marie | SVP, CHIEF ACCOUNTING OFFICER | S - Sale | $76.45 | -1,034 | 72,693 | -1% | -$79,049 | ||||||
| M | 2026-01-08 | PTCT | Ptc Therapeutics, Inc. | Pauwels Eric | CHIEF BUSINESS OFFICER | S - Sale | $77.02 | -7,348 | 80,141 | -8% | -$565,946 | |||||
2026-01-08 | PTCT | Ptc Therapeutics, Inc. | Klein Matthew B. | CEO | S - Sale | $76.45 | -2,514 | 394,453 | -1% | -$192,195 | ||||||
2026-01-08 | PTCT | Ptc Therapeutics, Inc. | Golden Lee Scott | EVP, CHIEF MEDICAL OFFICER | S - Sale | $76.45 | -866 | 92,428 | -1% | -$66,206 | ||||||
| M | 2026-01-08 | PTCT | Ptc Therapeutics, Inc. | Boulding Mark Elliott | EVP, CLO | S - Sale | $77.06 | -6,347 | 111,312 | -5% | -$489,081 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |